Purchase Order 75N95025P00251
Award Date
5/2/25
Potential Completion Date
5/1/28
Potential Value
$232K
Funding Federal Agency
National Institute on Aging
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10013, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
5
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $44,838.00, was made by the National Institute on Aging (NIA), a civilian agency under the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the procurement of Promethion flow cell packs and ligation sequencing kits, which are used in Oxford Nanopore's next-generation genomic sequencing platforms. The contract is a firm fixed-price purchase order with a...
This federal contract award, valued at $22,600, was issued by the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the procurement of SCIENTIFIC EQUIPMENT - PROMETHION FLOW CELLS, with a completion date of Nov 15, 2024. Oxford Nanopore Technologies is a provider of nanopore-based electronic systems for analyzing single molecules, including DNA, RNA,...
This federal contract award, valued at $304,104.91, was made by the National Institute on Aging (NIA) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the delivery of PromethION flow cells and accessories to support long-read sequencing on Oxford Nanopore's sequencing systems. This equipment will be used by the NIA's Center for Alzheimer's Disease and Related Dementias to identify causative genes for neurodegenerative diseases as part...
This is a $150,000.00 firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for a license and warranty for a PromethION 48 DNA/RNA sequencing system, with a period of performance through October 27, 2029. Oxford Nanopore Technologies has secured multiple prime contracts and...
This is a firm-fixed price purchase order awarded by the U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Aging to Oxford Nanopore Technologies Inc., a division of the parent company Oxford Nanopore Technologies PLC. The $355,400 contract is for the provision of full-length RNA sequencing supplies to support the work of the National Institute on Aging. The contract has a completion date of June 15, 2022 and was originally awarded on September 16,...
The National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, awarded a $197,755 firm-fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the delivery of a PROMETHION 24 THIRD GENERATION SEQUENCER to support the NIA's Computational Biology & Genomics Core, which provides next-generation sequencing services for aging-related research at the NIA Intramural...
The National Human Genome Research Institute (NHGRI), a civilian agency, awarded a $23,590.00 firm fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for the supply of 3 packs of 4 PromethION flow cell packs (RNA) with a period of performance through December 31, 2024. This award does not have a set-aside designation. Oxford Nanopore Technologies Inc. has secured numerous prime federal contract awards from agencies such as the National...
This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, is for the provision of nanopore flow-cells and a ligation kit. The $19,227.99 firm fixed-price purchase order was awarded by the Northeast Area division of the U.S. Department of Agriculture's Agricultural Research Service. The contract has an ultimate completion date of May 10, 2024. Oxford Nanopore has secured multiple federal contracts and Indefinite Delivery Vehicles (IDVs)...
This firm fixed price contract was awarded by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization. The $10,928.00 award is for the delivery of Oxford Nanopore's DNA sequencing flow cells and reagents to support long-read sequencing activities at the agency's DNA Sequencing Core. The contract has a completion date of November 7, 2023 and does not utilize any...
This federal contract award is for the delivery of PROMETHION FLOW CELL PACKS (RNA) to the National Human Genome Research Institute, which is part of the Department of Health and Human Services National Institutes of Health. The prime contractor is Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company that develops nanopore-based electronic systems for analyzing single molecules including DNA, RNA, and proteins. The contract has a firm fixed price of $11,568.00 and...